US 10316025
Substituted piperazine compounds and methods of use and use thereof
granted A61KA61K31/496A61K31/506
Quick answer
US patent 10316025 (Substituted piperazine compounds and methods of use and use thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/496, A61K31/506, A61K45/06, A61P